Natural Alternatives International (NASDAQ:NAII) Receives New Coverage from Analysts at StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of Natural Alternatives International (NASDAQ:NAII) in a report issued on Wednesday. The firm set a “buy” rating on the stock.

Separately, TheStreet downgraded shares of Natural Alternatives International from a “c” rating to a “d” rating in a research note on Tuesday, February 13th.

Natural Alternatives International Trading Up 2.7 %

Shares of NASDAQ NAII opened at $6.47 on Wednesday. Natural Alternatives International has a 1-year low of $5.06 and a 1-year high of $9.10. The company has a market cap of $39.40 million, a PE ratio of -9.24 and a beta of 0.58. The company has a current ratio of 4.06, a quick ratio of 2.59 and a debt-to-equity ratio of 0.11. The company has a 50-day moving average of $6.19 and a two-hundred day moving average of $6.24.

Natural Alternatives International (NASDAQ:NAII) last posted its quarterly earnings results on Tuesday, February 13th. The company reported ($0.52) earnings per share for the quarter. The business had revenue of $25.20 million for the quarter. Natural Alternatives International had a negative return on equity of 4.70% and a negative net margin of 3.22%.

Natural Alternatives International Company Profile

Natural Alternatives International, Inc engages in formulating, manufacturing, and marketing nutritional supplements in the United States, Europe, Australia, Asia, Mexico, and Canada. The company operates in two segments, Private-Label Contract Manufacturing, and Patent and Trademark Licensing. It offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.